A Study of Sintilimab Combined With Apatinib and Capecitabine in Advanced Hepatocellular Carcinoma
Clinical trial NCT04411706 · UNKNOWN
Trial details
- NCT number
- NCT04411706
- Sponsor
- Xin-Hua Xu
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-21
- Primary completion
- 2021-06-01
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.